BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7914453)

  • 1. Paclitaxel: a new antimitotic chemotherapeutic agent.
    Gotaskie GE; Andreassi BF
    Cancer Pract; 1994; 2(1):27-33. PubMed ID: 7914453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paclitaxel: a new antineoplastic agent for refractory ovarian cancer.
    Gregory RE; DeLisa AF
    Clin Pharm; 1993 Jun; 12(6):401-15. PubMed ID: 7691462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacological action of paclitaxel].
    Potemski P; Płuzańska A
    Pol Merkur Lekarski; 1999 Jan; 6(31):27-9. PubMed ID: 10344150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel (Taxol) in breast cancer.
    Arbuck SG; Dorr A; Friedman MA
    Hematol Oncol Clin North Am; 1994 Feb; 8(1):121-40. PubMed ID: 7908664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Paclitaxel (taxol): a review of its antitumor activity and toxicity in clinical studies].
    Yamazaki S; Sekine I; Saijo N
    Gan To Kagaku Ryoho; 1998 Mar; 25(4):605-15. PubMed ID: 9530372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of paclitaxel (Taxol) in squamous cell carcinoma of the head and neck.
    Forastiere AA
    Semin Oncol; 1993 Aug; 20(4 Suppl 3):56-60. PubMed ID: 8102018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel (Taxol) for the treatment of head and neck cancer.
    Forastiere AA
    Semin Oncol; 1994 Oct; 21(5 Suppl 8):49-52. PubMed ID: 7939763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel (Taxol): a review of its antitumor activity in clinical studies Minireview.
    Hájek R; Vorlicek J; Slavik M
    Neoplasma; 1996; 43(3):141-54. PubMed ID: 8841500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taxol: a new and effective anti-cancer drug.
    Slichenmyer WJ; Von Hoff DD
    Anticancer Drugs; 1991 Dec; 2(6):519-30. PubMed ID: 1687206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of paclitaxel (Taxol) in advanced lung cancer.
    Ettinger DS
    Semin Oncol; 1993 Aug; 20(4 Suppl 3):46-9. PubMed ID: 8102017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer.
    Nielsen LL; Lipari P; Dell J; Gurnani M; Hajian G
    Clin Cancer Res; 1998 Apr; 4(4):835-46. PubMed ID: 9563876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taxol: a promising new drug of the '90s.
    Rogers BB
    Oncol Nurs Forum; 1993; 20(10):1483-9. PubMed ID: 7904060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Taxol (paclitaxel), first molecule of a new class of cytotoxic agents: taxanes].
    Chazard M; Pellae-Cosset B; Garet F; Soares JA; Lucidi B; Lavail Y; Lenaz L
    Bull Cancer; 1994 Mar; 81(3):173-81. PubMed ID: 7894125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein nanoparticles as drug carriers in clinical medicine.
    Hawkins MJ; Soon-Shiong P; Desai N
    Adv Drug Deliv Rev; 2008 May; 60(8):876-85. PubMed ID: 18423779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taxol (paclitaxel): a novel anti-microtubule agent with remarkable anti-neoplastic activity.
    Foa R; Norton L; Seidman AD
    Int J Clin Lab Res; 1994; 24(1):6-14. PubMed ID: 7910054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Paclitaxel (Taxol)].
    Hájek R
    Cas Lek Cesk; 1996 Jun; 135(12):393-6. PubMed ID: 8706079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical pharmacology of paclitaxel (Taxol).
    Rowinsky EK; Donehower RC
    Semin Oncol; 1993 Aug; 20(4 Suppl 3):16-25. PubMed ID: 8102014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Camptothecin and taxol: discovery to clinic--thirteenth Bruce F. Cain Memorial Award Lecture.
    Wall ME; Wani MC
    Cancer Res; 1995 Feb; 55(4):753-60. PubMed ID: 7850785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodistributed erythema multiforme: paclitaxel-related, photosensitive conditions in patients with cancer.
    Cohen PR
    J Drugs Dermatol; 2009 Jan; 8(1):61-4. PubMed ID: 19180897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor targeting by covalent conjugation of a natural fatty acid to paclitaxel.
    Bradley MO; Webb NL; Anthony FH; Devanesan P; Witman PA; Hemamalini S; Chander MC; Baker SD; He L; Horwitz SB; Swindell CS
    Clin Cancer Res; 2001 Oct; 7(10):3229-38. PubMed ID: 11595719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.